Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296315) titled 'Confirmatory Clinical Study in Active Ulcerative Colitis' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: MRM Health NV
Condition:
Colitis, Ulcerative
Intervention:
Drug: Low-dose MH002
Drug: High-dose MH002
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: March 2026
Target Sample Size: 204
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov...